- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05538793
Deep Learning for the Discrimination Among Different Types of Keratits: a Nationwide Study
October 25, 2023 updated by: Ningbo Eye Hospital
Deep Learning for the Discrimination Among Bacterial, Fungal, Viral, Amebic and Noninfectious Keratitis: a Nationwide Study
Detecting the cause of keratitis fast is the premise of providing targeted therapy for reducing vision loss and preventing severe complications.
Due to overlapping inflammatory features, even expert cornea specialists have relatively poor performance in the identification of causative pathogen of infectious keraitis.
In this project, the investigators aim to develop an automated and accurate deep learning system to discriminate among bacterial, fungal, viral, amebic and noninfectious keratitis based on slit-lamp images and evaluated this system using the datasets obtained from mutiple independent clinical centers across China.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
10369
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Wenzhou, China
- Eye Hospital of Wenzhou Medical University
-
-
Zhejiang
-
Ningbo, Zhejiang, China
- Ningbo Eye Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 week to 100 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
Child, Adult, Older Adult
Description
Inclusion Criteria:
Slit-lamp images with sufficient diagnostic certainty and showing keratitis at the active phase.
Exclusion Criteria:
- Poor-quality images
- Images presenting mixed infections (i.e., cornea infected by two or more causative pathogens)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Other
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Area under the receiver operating characteristic curve of the deep learning system
Time Frame: 2020-2022
|
2020-2022
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Accuracy of the deep learning system
Time Frame: 2020-2022
|
2020-2022
|
|
Sensitivity of the deep learning system
Time Frame: 2020-2022
|
2020-2022
|
|
Specificity of the deep learning system
Time Frame: 2020-2022
|
2020-2022
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2020
Primary Completion (Actual)
September 30, 2023
Study Completion (Actual)
October 20, 2023
Study Registration Dates
First Submitted
September 11, 2022
First Submitted That Met QC Criteria
September 11, 2022
First Posted (Actual)
September 14, 2022
Study Record Updates
Last Update Posted (Actual)
October 27, 2023
Last Update Submitted That Met QC Criteria
October 25, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NEH2022091015
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.